Dementia drug use under scrutiny: are doctors prescribing correctly?

NCT ID NCT07313137

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at medical records of 683 older adults with dementia to see if their use of antiplatelet drugs (like aspirin) matched official guidelines. Researchers found that prescribing patterns varied across different types of dementia. The goal was to understand real-world practices and improve future care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

antiplatelet therapy

What this could lead to

If successful, this could help doctors prescribe antiplatelet drugs more appropriately for people with dementia.

What could go wrong

This is an observational study, not a treatment trial. It cannot prove whether antiplatelet therapy helps or harms dementia patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMENTIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.